Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)

Using data from the German Hepatitis C-Registry (Deutsche Hepatitis C-Register, DHC-R), we report the real-world safety and effectiveness of glecaprevir/pibrentasvir (GLE/PIB) treatment and its impact on patient-reported outcomes (PROs) in underserved populations who are not typically included in cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornberg, Markus, Stoehr, Albrecht, Naumann, Uwe, Teuber, Gerlinde, Klinker, Hartwig, Lutz, Thomas, Möller, Hjördis, Hidde, Dennis, Lohmann, Kristina, Simon, Karl-Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318383/
https://www.ncbi.nlm.nih.gov/pubmed/35891520
http://dx.doi.org/10.3390/v14071541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318383/
https://www.ncbi.nlm.nih.gov/pubmed/35891520
http://dx.doi.org/10.3390/v14071541

Ejemplares similares